FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
Comparision between GPES Solar IPO and Medicamen Organics IPO.
GPES Solar IPO is a SME Book Built Issue IPO proposed to list at NSE SME while Medicamen Organics IPO is a SME Book Built Issue proposed to list at NSE SME.
GPES Solar IPO | Medicamen Organics IPO | |
---|---|---|
Logo | ||
Issue Category | SME | SME |
Issue Type | IPO | IPO |
Process Type | Book Built Issue | Book Built Issue |
Listing At | NSE SME | NSE SME |
Lead Managers | Corporate Capitalventures Pvt Ltd | GYR Capital Advisors Private Limited |
Registrar | Bigshare Services Pvt Ltd | Kfin Technologies Limited |
Market Maker | Ss Corporate Securities Limited | Giriraj Stock Broking Private Limited |
DRHP | DRHP | DRHP |
RHP | RHP | RHP |
Anchor Investor | Anchor Investor | Anchor Investor |
IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of GPES Solar IPO is up to ₹30.79 Cr whereas the issue size of the Medicamen Organics IPO is up to ₹10.54 Cr. The final issue price of GPES Solar IPO is ₹94.00 per share and of Medicamen Organics IPO is ₹34.00 per share.
GPES Solar IPO | Medicamen Organics IPO | |
---|---|---|
Face Value | ₹10 per share | ₹10 per share |
Issue Price (Lower) | ₹90.00 per share | ₹32.00 per share |
Issue Price (Upper) | ₹94.00 per share | ₹34.00 per share |
Issue Price (Final) | ₹94.00 per share | ₹34.00 per share |
Discount (Retail) | ||
Discount (Employee) | ||
Market Lot Size | 1200 shares | 4000 shares |
Fresh Issue Size | 32,76,000 shares | 31,00,000 shares |
Fresh Issue Size (Amount) | up to ₹30.79 Cr | up to ₹10.54 Cr |
OFS Issue Size | ||
OFS Issue Size (Amount) | ||
Issue Size Total | 32,76,000 shares | 31,00,000 shares |
Issue Size Total (Amount) | up to ₹30.79 Cr | up to ₹10.54 Cr |
GPES Solar IPO opens on Jun 14, 2024, while Medicamen Organics IPO opens on Jun 21, 2024. The closing date of GPES Solar IPO and Medicamen Organics IPO is Jun 19, 2024, and Jun 25, 2024, respectively.
GPES Solar IPO | Medicamen Organics IPO | |
---|---|---|
Anchor Bid Date | Jun 13, 2024 | Jun 20, 2024 |
Issue Open | Jun 14, 2024 | Jun 21, 2024 |
Issue Close | Jun 19, 2024 | Jun 25, 2024 |
Basis Of Allotment (Tentative) | Jun 20, 2024 | Jun 26, 2024 |
Initiation of Refunds (Tentative) | Jun 21, 2024 | Jun 27, 2024 |
Credit of Share (Tentative) | Jun 21, 2024 | Jun 27, 2024 |
Listing date (Tentative) | Jun 24, 2024 | Jun 28, 2024 |
Anchor Lockin End date 1 | Jul 20, 2024 | Jul 26, 2024 |
Anchor Lockin End date 2 | Sep 18, 2024 | Sep 24, 2024 |
GPES Solar IPO P/E ratio is 21.44, as compared to Medicamen Organics IPO P/E ratio of 30.53.
GPES Solar IPO | Medicamen Organics IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Financial | GP Eco Solutions India Limited Financial Information (Restated)GP Eco Solutions India Limited's revenue increased by 25.08% and profit after tax (PAT) rose by 33.43% between the financial year ending with March 31, 2023 and March 31, 2022.
|
Medicamen Organics Limited Financial Information (Restated)Medicamen Organics Limited's revenue increased by 10.13% and profit after tax (PAT) rose by 151% between the financial year ending with March 31, 2024 and March 31, 2023.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Promoter Shareholding (Pre-Issue) | 86.4% | 81.21% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Promoter Shareholding (Post-Issue) | 62.23% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
P/E Ratio | 21.44 | 30.53 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Market Cap | ₹110.08 Cr. | ₹39.78 Cr. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ROE | 44.59%% | 19.90%% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ROCE | 26.51%% | 14.50%% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt/Equity | 1.11 | 0.83 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
EPS | ₹4.38 | ₹1.11 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
RoNW | 42.70%% | 15.83% |
In the GPES Solar IPO retail investors (RII) are offered 10,32,000 shares while in Medicamen Organics IPO retail investors are offered 10,32,000 shares. Qualified institutional buyers (QIB) are offered 5,89,200 shares in GPES Solar IPO and 5,84,000 shares in Medicamen Organics IPO.
GPES Solar IPO | Medicamen Organics IPO | |
---|---|---|
Anchor Investor Reserveration | 8,83,200 shares | 8,76,000 shares |
Market Maker Reserveration | 3,27,600 shares | 1,72,000 shares |
QIB | 5,89,200 shares | 5,84,000 shares |
NII | 4,44,000 shares | 4,40,000 shares |
RII | 10,32,000 shares | 10,28,000 shares |
Employee | 0 shares | 0 shares |
Others | ||
Total | 20,65,200 shares | 20,52,000 shares |
GPES Solar IPO subscribed 856.21x in total, whereas Medicamen Organics IPO subscribed 993.56x.
GPES Solar IPO | Medicamen Organics IPO | |
---|---|---|
QIB (times) | 236.64x | 173.03x |
NII (times) | 1,824.87x | 1,343.83x |
Big NII (times) | ||
Small NII (times) | ||
RII (times) | 793.20x | 1,309.77x |
Employee (times) | ||
Other (times) | ||
Total (times) | 856.21x | 993.56x |
Add a public comment...
Rs 0 Account Opening Fee
Free Eq Delivery & MF
Flat ₹20 Per Trade in F&O
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|